Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Restaurants across the U.S. are introducing “Ozempic menus” with smaller, protein-rich portions to cater to millions using ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

The researchers observed “significant” weight regain at eight, 12, and 20 weeks after discontinuation. They deduced that most patients gain back the weight they initially lost for an average of 20 ...

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...

Scientists have revealed a potential 'neurobiotic' sixth sense derived from direct communication between microorganisms and ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...